AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

8,314.00p
   
  • Change Today:
      38.00p
  • 52 Week High: 9,444.00p
  • 52 Week Low: 6,794.00p
  • Currency: UK Pounds
  • Shares Issued: 1,549.16m
  • Volume: 1,933,858
  • Market Cap: £128,797m
  • RiskGrade: 123
  • Beta: 0.36

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
85.82% above the market average85.82% above the market average85.82% above the market average85.82% above the market average85.82% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
1yr Revenue Growth
39.29% above the market average39.29% above the market average39.29% above the market average39.29% above the market average39.29% above the market average
3.03% below the sector average3.03% below the sector average3.03% below the sector average3.03% below the sector average3.03% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
5.08% below the market average5.08% below the market average5.08% below the market average5.08% below the market average5.08% below the market average
55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio Not Available
Price Book Ratio
87.3% below the market average87.3% below the market average87.3% below the market average87.3% below the market average87.3% below the market average
57.45% below the sector average57.45% below the sector average57.45% below the sector average57.45% below the sector average57.45% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
55.09% below the market average55.09% below the market average55.09% below the market average55.09% below the market average55.09% below the market average
26.67% below the sector average26.67% below the sector average26.67% below the sector average26.67% below the sector average26.67% below the sector average
Price Chg 3m
2.92% below the market average2.92% below the market average2.92% below the market average2.92% below the market average2.92% below the market average
36.67% above the sector average36.67% above the sector average36.67% above the sector average36.67% above the sector average36.67% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
32.94% below the market average32.94% below the market average32.94% below the market average32.94% below the market average32.94% below the market average
34.48% below the sector average34.48% below the sector average34.48% below the sector average34.48% below the sector average34.48% below the sector average
Momentum 20
99.88% below the market average99.88% below the market average99.88% below the market average99.88% below the market average99.88% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
37.99% above the market average37.99% above the market average37.99% above the market average37.99% above the market average37.99% above the market average
69.70% above the sector average69.70% above the sector average69.70% above the sector average69.70% above the sector average69.70% above the sector average
ROCE
84.09% above the market average84.09% above the market average84.09% above the market average84.09% above the market average84.09% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
97.36% above the market average97.36% above the market average97.36% above the market average97.36% above the market average97.36% above the market average
95.74% above the sector average95.74% above the sector average95.74% above the sector average95.74% above the sector average95.74% above the sector average
Forecast EPS
97.73% above the market average97.73% above the market average97.73% above the market average97.73% above the market average97.73% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
97.08% above the market average97.08% above the market average97.08% above the market average97.08% above the market average97.08% above the market average
93.94% above the sector average93.94% above the sector average93.94% above the sector average93.94% above the sector average93.94% above the sector average
Operating Profit Loss
98.82% above the market average98.82% above the market average98.82% above the market average98.82% above the market average98.82% above the market average
95.92% above the sector average95.92% above the sector average95.92% above the sector average95.92% above the sector average95.92% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
97.02% above the market average97.02% above the market average97.02% above the market average97.02% above the market average97.02% above the market average
95.65% above the sector average95.65% above the sector average95.65% above the sector average95.65% above the sector average95.65% above the sector average
Cash
97.87% above the market average97.87% above the market average97.87% above the market average97.87% above the market average97.87% above the market average
95.92% above the sector average95.92% above the sector average95.92% above the sector average95.92% above the sector average95.92% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
48.00% above the market average48.00% above the market average48.00% above the market average48.00% above the market average48.00% above the market average
61.90% above the sector average61.90% above the sector average61.90% above the sector average61.90% above the sector average61.90% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
0.55% below the market average0.55% below the market average0.55% below the market average0.55% below the market average0.55% below the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average
Brokers Percent Neutral
97.4% below the market average97.4% below the market average97.4% below the market average97.4% below the market average97.4% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 8,314.00p
Change Today 38.00p
% Change 0.46 %
52 Week High 9,444.00p
52 Week Low 6,794.00p
Volume 1,933,858
Shares Issued 1,549.16m
Market Cap £128,797m
Beta 0.36
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
84.65% below the market average84.65% below the market average84.65% below the market average84.65% below the market average84.65% below the market average
26.53% above the sector average26.53% above the sector average26.53% above the sector average26.53% above the sector average26.53% above the sector average
Price Trend
21.22% above the market average21.22% above the market average21.22% above the market average21.22% above the market average21.22% above the market average
6.67% above the sector average6.67% above the sector average6.67% above the sector average6.67% above the sector average6.67% above the sector average
Income
33.33% below the market average33.33% below the market average33.33% below the market average33.33% below the market average33.33% below the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Growth
87.43% above the market average87.43% above the market average87.43% above the market average87.43% above the market average87.43% above the market average
70.59% above the sector average70.59% above the sector average70.59% above the sector average70.59% above the sector average70.59% above the sector average

What The Brokers Say

Strong Buy 22
Buy 3
Neutral 2
Sell 0
Strong Sell 0
Total 27
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 12-Aug-21 25-Feb-21
Paid 13-Sep-21 29-Mar-21
Amount 90.00¢ 190.00¢

Trades for 01-Dec-2021

Time Volume / Share Price
16:38 220 @ 8,314.00p
16:35 796,803 @ 8,314.00p
16:30 62 @ 8,327.00p
16:29 63 @ 8,326.00p
16:29 44 @ 8,326.00p

Top of Page